Implementation of goal-directed fluid therapy during hip revision arthroplasty: a matched cohort study

被引:0
|
作者
Habicher, Marit [1 ,2 ]
Balzer, Felix [1 ,2 ]
Mezger, Viktor [1 ,2 ]
Niclas, Jennifer [1 ,2 ]
Mueller, Michael [2 ]
Perka, Carsten [2 ,3 ]
Kraemer, Michael [1 ,2 ,3 ]
Sander, Michael [1 ,4 ]
机构
[1] Campus Charite Mitte, Charite Univ Hosp Berlin, Dept Anaesthesiol & Intens Care Med, Berlin, Germany
[2] Campus Virchow Klinikum, Berlin, Germany
[3] Campus Charite Mitte, Charite Univ Hosp Berlin, Dept Orthopaed, Ctr Musculoskeletal Surg, Berlin, Germany
[4] Justus Liebig Univ, Dept Anaesthesiol Intens Care Med & Pain Therapy, Giessen, Germany
关键词
Goal-directed fluid therapy; Hip surgery; Postoperative outcome; Haemodynamic monitoring; Hip revision arthroplasty;
D O I
10.1186/s13741-016-0056-x
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background: Several randomized controlled trials (RCTs) have demonstrated that intraoperative goal-directed fluid therapy (GDFT) can decrease postsurgical complications in patients undergoing major abdominal surgery. However, very few studies have demonstrated the value of goal-directed therapy (GDT) in patients undergoing orthopaedic surgery and confirmed it is as useful in real-life conditions. Therefore, we initiated a GDFT implementation programme in patients undergoing hip revision arthroplasty in order to assess its effects on postoperative complications (e.g. infection, cardiac, neurological, renal) (primary outcome) and hospital and intensive care unit (ICU) length of stay (secondary outcomes). Methods: We developed a GDFT protocol for the haemodynamic management of patients undergoing hip revision arthroplasty. The GDFT protocol was based on continuous monitoring and optimization of stroke volume during the surgical procedure. From December 2012 and for a period of 17 months, 130 patients were treated according to the GDFT protocol (GDFT group). The pre-, intra-, and postoperative characteristics of patients from the GDFT group were compared to those of 130 historical matched patients (control group) who had the same surgery between January 2011 and August 2012. Results: Patients from the GDFT and from the control group were comparable in terms of age, comorbidities, and P-POSSUM score. Duration of anaesthesia and surgery were also comparable. The GDFT group had a significantly lower morbidity rate (49.2 vs. 66.9%; p = 0.006) and a shorter median hospital length of stay (11 days (9-15) vs. 9 days (8-12); p = 0.003) than the control group. Patients from the control group post-anaesthesia care unit (PACU)/ICU stayed significantly longer at PACU/ICU than patients from the GDFT group (control group vs. GDFT group, 960 min (360-1210) vs. 400 min (207-825); p < 0.001) Patients from the GDFT group received less crystalloids but more colloids during surgery. They also received more often inotropic therapy. Conclusions: In patients undergoing hip revision arthroplasty, the implementation of GDT as a new standard operating procedure was successful and associated with reduced postsurgical complications, most importantly a reduction in postoperative bleeding as well as hospital and ICU stay.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] Potential return on investment for implementation of perioperative goal-directed fluid therapy in major surgery: a nationwide database study
    Michard, Frederic
    Mountford, William K.
    Krukas, Michelle R.
    Ernst, Frank R.
    Fogel, Sandy L.
    PERIOPERATIVE MEDICINE, 2015, 4
  • [22] Potential return on investment for implementation of perioperative goal-directed fluid therapy in major surgery: a nationwide database study
    Frederic Michard
    William K. Mountford
    Michelle R. Krukas
    Frank R. Ernst
    Sandy L. Fogel
    Perioperative Medicine, 4 (1)
  • [23] Goal-directed fluid therapy in gastrointestinal cancer surgery: A prospective randomized study
    Akyol, Duygu
    Cukurova, Zafer
    Tulubas, EvrimKucur
    Yildiz, Gunes Ozlem
    Sabaz, Mehmet Suleyman
    JOURNAL OF ACUTE DISEASE, 2022, 11 (02) : 52 - 58
  • [24] Implementation of Early Goal-Directed Therapy: Which Components Are Not Performed?
    Ward, M. J.
    Deledda, J. M.
    Smith, C. L.
    Hart, K. W.
    Lindsell, C. J.
    Gibler, W. B.
    Wright, S. W.
    ANNALS OF EMERGENCY MEDICINE, 2010, 56 (03) : S58 - S59
  • [25] Reply to: implementation of closed-loop-assisted intra-operative goal-directed fluid therapy during surgery
    Coeckelenbergh, Sean
    Van der Linden, Philippe
    Rinehart, Joseph
    Joosten, Alexandre
    EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2019, 36 (04) : 304 - 305
  • [26] Goal-Directed Fluid Therapy in Ovarian Cancer Cytoreductive Surgery
    Goswami, Jyotsna
    ANESTHESIA AND ANALGESIA, 2023, 136 : 797 - 797
  • [27] Crystalloid or colloid for goal-directed fluid therapy in colorectal surgery
    Yates, D. R. A.
    Davies, S. J.
    Milner, H. E.
    Wilson, R. J. T.
    BRITISH JOURNAL OF ANAESTHESIA, 2014, 112 (02) : 281 - 289
  • [28] Does the Device Matter in Goal-Directed Fluid Therapy? Response
    Joshi, Girish R.
    Kehlet, Henrik
    ANESTHESIA AND ANALGESIA, 2016, 123 (04): : 1062 - 1062
  • [29] Goal-directed fluid therapy in major elective rectal surgery
    Srinivasa, Sanket
    Taylor, Matthew H. G.
    Singh, Primal P.
    Lemanu, Daniel P.
    MacCormick, Andrew D.
    Hill, Andrew G.
    INTERNATIONAL JOURNAL OF SURGERY, 2014, 12 (12) : 1467 - 1472
  • [30] Crystalloids should be second choice for goal-directed fluid therapy
    Hahn, Robert G.
    EUROPEAN JOURNAL OF ANAESTHESIOLOGY, 2020, 37 (05) : 414 - 415